Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis unit.
Denton
M
M
Littlewood
J M
JM
Brownlee
K G
KG
Conway
S P
SP
Todd
N J
NJ
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D003428:Cross Infection / Q000382:microbiology* / Q000635:transmission; D003550:Cystic Fibrosis / Q000150:complications* / Q000382:microbiology; D004739:England; D006801:Humans; D010044:Outpatient Clinics, Hospital; D011552:Pseudomonas Infections / Q000382:microbiology* / Q000635:transmission; D011550:Pseudomonas aeruginosa / Q000187:drug effects*; D018440:beta-Lactam Resistance; D047090:beta-Lactams
D000900:Anti-Bacterial Agents; D047090:beta-Lactams